Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

ACR/ARHP Annual Meeting 2012: Global Perspectives Make Rheumatology Meeting an International Affair

Susan Bernstein  |  Issue: January 2013  |  January 1, 2013

Annual meeting attendees visit the Poster and Exhibit Halls.
Annual meeting attendees visit the Poster and Exhibit Halls.

WASHINGTON, D.C.—In recent years, the ACR/ARHP Annual Meeting has been an international affair, attracting scientific attendees from more than 100 countries. Each of these rheumatology clinicians, researchers, fellows, and other health professionals came to the meeting, held this year in Washington, D.C., from November 9–14, for individual reasons.

“I am most interested in the scleroderma sessions,” said Dilia Giuggioli, MD, a rheumatologist at the University of Modena Medical School in Modena and Reggio Emilia, Italy. She conducts research on connective tissue diseases and treats scleroderma patients. “But in this meeting, there are only a few sessions on scleroderma. I don’t know why, but it’s mostly rheumatoid arthritis (RA). I am here to see some news on scleroderma, but today there was only one session on animal models. But we are clinicians,” she said.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Despite the paucity of scleroderma-focused sessions this year, Dr. Giuggioli said the main reason she tries to attend ACR annual meetings is to talk with other rheumatologists and compare views on treatment approaches and patient care. However, travel expenses make attendance difficult. “It is very expensive, and in Italy right now, we are going through a very bad period.”

Rheumatologist Malcolm Smith, PhD, traveled from Adelaide, South Australia to attend this year’s meeting, and selects sessions that improve his practice with his patients, he said. Dr. Smith is a professor and researcher at Flinders Medical Centre in Adelaide, and also works in private practice. “I also choose sessions related to my own research. For example, I went to the Hench Lecture on synovial immunopathology, because it is of interest to me personally,” Dr. Smith said.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Since Adelaide is more than 10,000 miles from Washington, D.C., Dr. Smith combines his trip to the annual meeting with visits to friends who live in the area and stops at local museums. He also planned to visit his daughter in Los Angeles afterward. “I’m making the most of this trip because it is a long way from home,” he said.

Traveling to the meeting takes less time for Nadia Gibson, MD, a rheumatologist at Via Christi Clinic in Wichita, Kansas. “I’m here just to update myself on what’s going on. I’m attending a few sessions pertaining to lupus management, and I am also attending sessions on myositis and the use of infliximab,” said Dr. Gibson, who finished her fellowship a year ago. She is a graduate of Howard University College of Medicine in Washington, D.C., so she’s very familiar with the city. “I’ve liked the meeting so far, and I’ve only been once in the past. I guess in the future, I may not be able to come as often due to patients.”

Page: 1 2 3 | Single Page
Share: 

Filed under:Education & TrainingMeeting Reports Tagged with:ACR/ARHP Annual MeetingEducation

Related Articles
    Lost and found

    The History of ACE Inhibitors in Scleroderma Renal Crisis

    February 16, 2021

    Scleroderma renal crisis is a true medical emergency in rheumatology, one that requires prompt diagnosis and treatment. Here, we review the historic introduction of the angiotensin-converting enzyme inhibitors in this context, and highlight management and key questions moving forward. Background Awareness of renal disease in scleroderma dates back many years. The revered physician William Osler…

    Plan Now to Attend the 2016 ACR/ARHP Annual Meeting

    Plan Now to Attend the 2016 ACR/ARHP Annual Meeting

    August 10, 2016

    Where can you network with more than 16,000 professionals in the field of rheumatology? Where you can hear about promising research and best practices from industry leaders? How can you find out about new treatments and technologies on the horizon? You guessed it—at the 2016 ACR/ARHP Annual Meeting, to be held Nov. 11–16. As if…

    ACR Convergence: Stronger Than Ever After More Than 8 Decades

    July 13, 2022

    Like solving sudoku, planning the ACR annual meeting requires an ability to recognize patterns and employ focused logical thinking, all the while remaining undaunted by the various paths possible to complete a grid from what looks like, at initial glance, an incomprehensible labyrinth of options. The patterns in this situation are not numbers, but sessions,…

    Diffuse Scleroderma: A 1991 Case Through the Lens of Today

    Diffuse Scleroderma: A 1991 Case Through the Lens of Today

    February 17, 2018

    The year was 1991. It was my first Tuesday as a rheumatology fellow at the University of Pittsburgh’s Presbyterian Hospital. Navigating a maze of buildings and hallways, I delivered myself to the entrance to the scleroderma clinic. Running late and not knowing whether there was a separate entrance for staff, I clicked open the door….

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences